Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility
- PMID: 37067721
- DOI: 10.1007/s11894-023-00868-7
Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility
Abstract
Purpose of review: Parkinson's disease and diabetes affect an increasing proportion of the aging global population. Both conditions extensively affect gastrointestinal (GI) motility with similar and differing clinical symptoms. Nonetheless, GI symptoms in Parkinson's disease and diabetes pose significant morbidity and impairment of quality of life. Their pathophysiology is poorly understood, and therefore, effective treatment options are lacking.
Recent findings: Parkinson's disease patients have oropharyngeal dysphagia and constipation. They also have mild or absent upper GI symptoms associated with delayed gastric emptying, which is prevalent in 70% of patients. Delayed gastric emptying in Parkinson's disease leads to erratic medication absorption and fluctuating motor symptoms. Half of diabetics have upper GI symptoms, which correlate to gastric emptying and changes in brain activity of the insular cortex. The majority of diabetics also have constipation. Diabetics have an increased risk for developing Parkinson's disease and anti-diabetic medications are associated with risk reduction of developing Parkinson's disease. Hyperglycemia is associated with advanced glycated end products formation and acceleration of α-synuclein aggregation. GLP-1 receptor agonists have also demonstrated efficacy in improving motor symptoms and cognition in Parkinson's disease patients with diabetes. Parkinson's disease and diabetes are pan-enteric disorders with significant GI symptoms and impairment of gut motility. Both conditions have synergistic pathophysiologies that propagate neurodegenerative changes. Treatment options for GI symptoms in diabetic and Parkinson's disease patients are lacking. Anti-diabetic treatment improves motor symptoms in Parkinson's disease, however, its effect on GI symptoms is unclear.
Keywords: Diabetes; GLP-1 receptor agonists; Gastrointestinal; Gut-brain axis; Nonmotor symptoms; Parkinson’s Disease.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The fixel GI Parkinson's research and integrated support model (PRISM).J Parkinsons Dis. 2025 May;15(3):573-584. doi: 10.1177/1877718X251335047. Epub 2025 Apr 17. J Parkinsons Dis. 2025. PMID: 40241494
-
Gut dysfunction in Parkinson's disease.World J Gastroenterol. 2016 Jul 7;22(25):5742-52. doi: 10.3748/wjg.v22.i25.5742. World J Gastroenterol. 2016. PMID: 27433087 Free PMC article. Review.
-
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.Parkinsonism Relat Disord. 2015 Dec;21(12):1407-14. doi: 10.1016/j.parkreldis.2015.10.011. Epub 2015 Oct 21. Parkinsonism Relat Disord. 2015. PMID: 26499757 Review.
-
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.Expert Opin Pharmacother. 2015;16(16):2449-64. doi: 10.1517/14656566.2015.1086747. Epub 2015 Sep 16. Expert Opin Pharmacother. 2015. PMID: 26374094 Review.
-
Gastrointestinal dysmotility in rodent models of Parkinson's disease.Am J Physiol Gastrointest Liver Physiol. 2024 Apr 1;326(4):G345-G359. doi: 10.1152/ajpgi.00225.2023. Epub 2024 Jan 23. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38261717 Free PMC article. Review.
Cited by
-
Lactose malabsorption and intolerance in older adults.Curr Opin Clin Nutr Metab Care. 2024 Jul 1;27(4):333-337. doi: 10.1097/MCO.0000000000001045. Epub 2024 Jun 6. Curr Opin Clin Nutr Metab Care. 2024. PMID: 38836813 Free PMC article. Review.
-
Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.Int J Mol Sci. 2025 Mar 24;26(7):2942. doi: 10.3390/ijms26072942. Int J Mol Sci. 2025. PMID: 40243562 Free PMC article. Review.
-
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358. Int J Mol Sci. 2024. PMID: 38673943 Free PMC article. Review.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
-
- Dorsey ER, et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–53. - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials